PortfoliosLab logo

Biocept, Inc. (BIOC)

Equity · Currency in USD · Last updated Mar 24, 2023

Share Price Chart

Loading data...


The chart shows the growth of $10,000 invested in Biocept, Inc. in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $0 for a total return of roughly -100.00%. All prices are adjusted for splits and dividends.

BIOC (Biocept, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with BIOC

Biocept, Inc.


Biocept, Inc. had a return of -43.40% year-to-date (YTD) and -85.85% in the last 12 months. Over the past 10 years, Biocept, Inc. had an annualized return of -67.49%, while the S&P 500 had an annualized return of 9.32%, indicating that Biocept, Inc. did not perform as well as the benchmark.

1 month-44.44%-3.20%
6 months-62.03%4.19%
1 year-85.85%-12.48%
5 years (annualized)-68.95%8.83%
10 years (annualized)-67.49%9.32%

Monthly Returns Heatmap


Sharpe Ratio Chart

The Sharpe ratio shows whether the portfolio's excess returns are due to smart investment decisions or a result of taking a higher risk. The higher a portfolio's Sharpe ratio, the better its risk-adjusted performance.

The current Biocept, Inc. Sharpe ratio is -1.12. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.

The chart below displays rolling 12-month Sharpe Ratio.

BIOC (Biocept, Inc.)
Benchmark (^GSPC)

Dividend History

Biocept, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.

BIOC (Biocept, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below shows the maximum drawdowns of the Biocept, Inc.. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.

The maximum drawdown since January 2010 for the Biocept, Inc. is 100.00%, recorded on Mar 17, 2023. The portfolio has not recovered from it yet.



To Bottom


To Recover



-100%Feb 19, 20142286Mar 17, 2023
-7.98%Feb 6, 20141Feb 6, 20147Feb 18, 20148

Volatility Chart

Current Biocept, Inc. volatility is 258.63%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.

BIOC (Biocept, Inc.)
Benchmark (^GSPC)